PATH
Menu

Filter browse results

Total results with these characteristics: 102

Subject: Reproductive health > Cervical cancer prevention

Page 2 of 6
Directions in Global Health (Volume 10, Issue 1)

This issue of Directions in Global Health features work by OneWorld Health, PATH’s drug development program, to lead development of innovative methods to enhance the supply of artemisinin, a key ingredient in malaria treatments. It includes a commentary by Dr. Ponni Subbiah, who directs PATH’s drug development efforts. Other articles cover work to improve cervical cancer screening, protect infants from respiratory syncytial virus, increase access to family planning, and strengthen and expand use of human milk banking.

Publication date: May 2013

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 5, Issue 3)

This issue of Directions in Global Health describes PATH's work to control and prevent diarrheal disease, reach out to young scouts in Kenya and Uganda with HIV/AIDS information, assess the impact of malaria control efforts in Zambia, conduct DHS surveys, and shape HPV vaccine introduction in Peru.

Author: PATH

Publication date: December 2008

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 6, Issue 1)

This special issue of Directions in Global Health highlights PATH’s work to advance technologies to improve global health. Featured technologies include low-cost tests to screen for cervical cancer, a new vaccine to protect against meningitis in Africa, products to prevent diarrheal disease, and Ultra Rice food fortification technology. The issue also includes a summary of PATH’s approach to developing and introducing innovative health technologies.

Publication date: May 2009

Region: Global

Part of series: Directions in Global Health

Directions in Global Health (Volume 8, Issue 2)

This issue of Directions in Global Health features PATH’s work to address noncommunicable diseases, such as diabetes and cancer. It also covers efforts to improve health in Kenya, build global and country capacity for influenza control, improve gender equity in China, and integrate health services for better outcomes.

Publication date: December 2011

Region: Global

Part of series: Directions in Global Health

An E6 Oncoprotien Based Diagnostic Test for Cervical Pre-Cancer and Cancer

This poster describes the AV Avantage HPV E6 Test and the results from a small clinical pilot study. The AV Avantage HPV E6 Test uses high affinity mAb for the specific capture and detection of high-risk HPV-E6 oncoproteins in a lateral flow–based format. Presented at: 26th International Papillomavirus Conference, July 3, 2010; Montreal, Canada.

Author: Berard-Bergery M, Bisht A, Ho M, et al

Publication date: July 2010

Region: Global

Effectiveness, Safety and Acceptability of Cryotherapy: A Systematic Literature Review

The main objective of the review was to examine the available data on the effectiveness, safety, and acceptability of cryotherapy, and to communicate the evidence base to health professionals and policy makers in developing countries.

Author: Castro W; Gage J; Gaffikin L; Ferreccio C; Sellors J; Sherris J; Blumenthal P

Publication date: 2003

Region: Global

Part of series: Cervical Cancer Prevention: Issues in Depth

Evaluating HPV Vaccination Pilots: Practical Experience From PATH

This unit of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website provides methods and tools for designing and conducting an evaluation of a human papillomavirus (HPV) vaccination pilot or demonstration project. It also gives practical examples of using the results to refine an HPV vaccine delivery strategy for national scale-up.

Publication date: 2012

Region: Global

Evaluating HPV Vaccine Delivery Strategies in Vietnam

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

Publication date: December 2010

Region: Asia

How Can We Prevent Cervical Cancer? A Guide for Community Facilitators

The community facilitator's guide, How Can We Prevent Cervical Cancer? was developed for use by community promotion teams as part of a cervical cancer prevention program in San Mart

Publication date: 2002

Region: Latin America

HPV and Cervical Cancer: Unique Challenges and Opportunities for Disease Prevention

HPV and cervical cancer

Author: Herdman C

Publication date: 2005

Region: Global

HPV DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-resource Settings

Author: Sherris J; Herdman C; Malloy C

Publication date: 2000

Region: Global

HPV Testing: Promise and Challenges

Publication date: 2003

Region: Global

HPV Vaccination in Africa: Lessons Learned From a Pilot Program in Uganda

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: January 2011

Region: Global

Part of series: HPV vaccination project lessons learned reports

HPV Vaccination in Latin America: Lessons Learned From a Pilot Program in Peru

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: December 2010

Region: Global

Part of series: HPV vaccination project lessons learned reports

HPV Vaccination in Southeast Asia: Lessons Learned From a Pilot Program in Vietnam

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Vietnam by PATH, the Vietnam National Institute of Hygiene and Epidemiology, and the Vietnam National Center for Health Education and Communication through the HPV Vaccines: Evidence for Impact project. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in Southeast Asia, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: November 2012

Region: Asia

Part of series: HPV vaccination project lessons learned reports

HPV Vaccine Adoption in Developing Countries: Cost and Financing Issues

Financing the human papillomavirus (HPV) vaccine and mobilizing resources to support new delivery mechanisms will constitute some of the most significant challenges to achieving widespread HPV vaccination in the developing world. Country decision-makers will need to weigh the value of HPV vaccines against other national health priorities, against other vaccines entering the market, and, for some countries, against expanding coverage of existing vaccines. With these cost and financing obstacles resolved, developing countries would be able to build robust programs to immunize adolescents and thus dramatically reduce the incidence of cervical cancer.

Publication date: December 2007

Region: Global

HPVflash

HPVflash is an email news bulletin that disseminates useful cervical cancer prevention information, including updates on vaccines against the human papillomavirus, to interested persons worldwide. HPVflash emails are emailed only a few times a year.

Publication date: 2014

Region: Global

Part of series: E-newsletters

Implementing HPV Vaccination Programs: Practical Experience From PATH

This document offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

Publication date: 2011

Region: Global

Improving Reproductive Health Through Innovation: PATH Increases Access to Products, Services, and Information

This fact sheet highlights PATH's work to address family planning needs, provide better methods of protection against sexually transmitted infections and HIV, and improve diagnosis and treatment of women's cancers in low-resource settings.

Publication date: October 2013

Region: Global

Part of series: Areas of focus fact sheets

Improving Screening Coverage Rates of Cervical Cancer Prevention Programs: A Focus on Communities

This paper describes the community focus taken by ACCP projects from 1999 to 2004 in eight countries: El Salvador, India, South Africa, Thailand, Ghana, Kenya, Peru, and Bolivia. We include an overview of the various community involvement strategies that were used to increase screening coverage, and we present lessons learned about how to meet women

Author: Coffey P; Arossi S; Bradley J; Dzuba I; White SC; ACCP Community Involvement Affinity Group

Publication date: 2004

Region: Global

Part of series: Cervical Cancer Prevention: Issues in Depth

Page 2 of 6